345 related articles for article (PubMed ID: 27685104)
1. Secondary cancer-incidence risk estimates for external radiotherapy and high-dose-rate brachytherapy in cervical cancer: phantom study.
Lee B; Ahn SH; Kim H; Son J; Sung J; Han Y; Huh SJ; Kim JS; Kim DW; Yoon M
J Appl Clin Med Phys; 2016 Sep; 17(5):124-132. PubMed ID: 27685104
[TBL] [Abstract][Full Text] [Related]
2. EVALUATION OF SECONDARY DOSE AND CANCER RISK FOR OUT-OF-FIELD ORGAN IN ESOPHAGEAL CANCER IMRT IN A CHINESE HOSPITAL USING ATOM PHANTOM MEASUREMENTS.
Qi Y; He L; Wang Z; Liu Y; Liu H; Huo W; Xu XG; Chen Z
Radiat Prot Dosimetry; 2017 Dec; 177(4):389-396. PubMed ID: 28472430
[TBL] [Abstract][Full Text] [Related]
3. Monte carlo study of organ doses and related risk for cancer in Tanzania from scattered photons in cervical radiation treatment involving Co-60 source.
Suleiman SA; Qi Y; Chen Z; Xu XG
Phys Med; 2019 Jun; 62():13-19. PubMed ID: 31153393
[TBL] [Abstract][Full Text] [Related]
4. Second cancer incidence risk estimates using BEIR VII models for standard and complex external beam radiotherapy for early breast cancer.
Donovan EM; James H; Bonora M; Yarnold JR; Evans PM
Med Phys; 2012 Oct; 39(10):5814-24. PubMed ID: 23039620
[TBL] [Abstract][Full Text] [Related]
5. MONTE CARLO SIMULATION OF OUT-OF-FIELD ORGAN DOSES AND CANCER RISK IN TANZANIA FOR RADIATION THERAPY OF UNILATERAL RETINOBLASTOMA USING A 60Co UNIT.
Suleiman SA; Qi Y; Pi Y; George Xu X
Radiat Prot Dosimetry; 2018 May; 179(3):263-270. PubMed ID: 29216393
[TBL] [Abstract][Full Text] [Related]
6. Calculated organ doses using Monte Carlo simulations in a reference male phantom undergoing HDR brachytherapy applied to localized prostate carcinoma.
Candela-Juan C; Perez-Calatayud J; Ballester F; Rivard MJ
Med Phys; 2013 Mar; 40(3):033901. PubMed ID: 23464344
[TBL] [Abstract][Full Text] [Related]
7. Estimation of effective imaging dose and excess absolute risk of secondary cancer incidence for four-dimensional cone-beam computed tomography acquisition.
Yuasa Y; Shiinoki T; Onizuka R; Fujimoto K
J Appl Clin Med Phys; 2019 Nov; 20(11):57-68. PubMed ID: 31593377
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo study of organ doses and related risk for cancer in Algeria from scattered neutrons in prostate treatment involving 3D-CRT.
Alem-Bezoubiri A; Suleiman SA; Behidj I; Mazrou H; Chami AC
Appl Radiat Isot; 2022 Feb; 180():110065. PubMed ID: 34933226
[TBL] [Abstract][Full Text] [Related]
9. Toward automated and personalized organ dose determination in CT examinations - A comparison of two tissue characterization models for Monte Carlo organ dose calculation with a Therapy Planning System.
Källman HE; Traneus E; Ahnesjö A
Med Phys; 2019 Feb; 46(2):1012-1023. PubMed ID: 30582891
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive evaluation of adaptive daily planning for cervical cancer HDR brachytherapy.
Meerschaert R; Nalichowski A; Burmeister J; Paul A; Miller S; Hu Z; Zhuang L
J Appl Clin Med Phys; 2016 Nov; 17(6):323-333. PubMed ID: 27929505
[TBL] [Abstract][Full Text] [Related]
11. Imaging doses and secondary cancer risk from kilovoltage cone-beam CT in radiation therapy.
Kim DW; Chung WK; Yoon M
Health Phys; 2013 May; 104(5):499-503. PubMed ID: 23532078
[TBL] [Abstract][Full Text] [Related]
12. Exposure of remote organs and associated cancer risks from tangential and multi-field breast cancer radiotherapy.
Simonetto C; Rennau H; Remmele J; Sebb S; Kundrát P; Eidemüller M; Wolf U; Hildebrandt G
Strahlenther Onkol; 2019 Jan; 195(1):32-42. PubMed ID: 30350118
[TBL] [Abstract][Full Text] [Related]
13. Long-term risks of secondary cancer for various whole and partial breast irradiation techniques.
Hoekstra N; Fleury E; Merino Lara TR; van der Baan P; Bahnerth A; Struik G; Hoogeman M; Pignol JP
Radiother Oncol; 2018 Sep; 128(3):428-433. PubMed ID: 29914648
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy-induced secondary cancer risk for breast cancer: 3D conformal therapy versus IMRT versus VMAT.
Lee B; Lee S; Sung J; Yoon M
J Radiol Prot; 2014 Jun; 34(2):325-31. PubMed ID: 24705154
[TBL] [Abstract][Full Text] [Related]
15. Tissue doses from radiotherapy of cancer of the uterine cervix.
Stovall M; Smith SA; Rosenstein M
Med Phys; 1989; 16(5):726-33. PubMed ID: 2509867
[TBL] [Abstract][Full Text] [Related]
16. Organ doses evaluation for chest computed tomography procedures with TL dosimeters: Comparison with Monte Carlo simulations.
Giansante L; Martins JC; Nersissian DY; Kiers KC; Kay FU; Sawamura MVY; Lee C; Gebrim EMMS; Costa PR
J Appl Clin Med Phys; 2019 Jan; 20(1):308-320. PubMed ID: 30508315
[TBL] [Abstract][Full Text] [Related]
17. Out-of-field organ doses and associated radiogenic risks from para-aortic radiotherapy for testicular seminoma.
Mazonakis M; Berris T; Varveris C; Lyraraki E; Damilakis J
Med Phys; 2014 May; 41(5):051702. PubMed ID: 24784368
[TBL] [Abstract][Full Text] [Related]
18. Estimation of lifetime attributable risks (LARs) of cancer associated with abdominopelvic radiotherapy treatment planning computed tomography (CT) simulations.
Bagherzadeh S; Jabbari N; Khalkhali HR
Int J Radiat Biol; 2018 May; 94(5):454-461. PubMed ID: 29528791
[TBL] [Abstract][Full Text] [Related]
19. Direction-modulated brachytherapy for high-dose-rate treatment of cervical cancer. I: theoretical design.
Han DY; Webster MJ; Scanderbeg DJ; Yashar C; Choi D; Song B; Devic S; Ravi A; Song WY
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):666-73. PubMed ID: 24751413
[TBL] [Abstract][Full Text] [Related]
20. Determination of spatial dose distribution in UCC treatments with LDR brachytherapy using Monte Carlo methods.
Benites-Rengifo JL; Vega-Carrillo HR
Appl Radiat Isot; 2018 Nov; 141():224-227. PubMed ID: 29789200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
